Beam Therapeutics Inc. · NASDAQ:BEAM
Simon Amy received 31,750 Beam Therapeutics Inc. shares as an award (Form 4)
Traded Mar 31, 2026 · Filed Apr 2, 2026
On Mar 31, 2026, Simon Amy (Chief Medical Officer) received 31,750 Beam Therapeutics Inc. shares as an award, leaving 109,114 shares. Filed Apr 2, 2026 (Form 4).
- Awarded
- 31,750 shares
- Holding after
- 109,114 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Common Stock | Award | 31,750 | 109,114 | Direct |
Source
Related
- Beam Therapeutics Inc.
- Simon Amy
- Beam Therapeutics Inc. shareholders
- Form 4 · Simon Amy · Jul 29, 2026
- Form 4 · Simon Amy · Jul 2, 2026
- Form 4 · Simon Amy · Apr 6, 2026
- Form 4 · Evans John M. · Oct 16, 2026
- Form 4 · Cavanagh Bethany J · Oct 2, 2026
- Form 4 · Ciaramella Giuseppe · Sep 25, 2026
- Schedule 13G/A · ARK Investment Management LLC · Aug 14, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026